Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Recombinant Erythropoietin, By Drug Type
     • Market Recombinant Erythropoietin, By Application
     • Market Recombinant Erythropoietin, By Distribution Channel
     • Market Recombinant Erythropoietin, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
       • Rising prevalence of chronic kidney disease (ckd)
     • Restraints
       • Stringent Regulatory Requirements
     • Opportunities
       • Emerging Markets
   • Impact Analysis
   • Key Highlights
   • Regulatory Scenario
   • Product launch/Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Merger and Acquisition Scenario
4. Recombinant Erythropoietin Market – Impact of Coronavirus (COVID-19) Pandemic
   • COVID-19 Epidemiology
   • Supply Side and Demand Side Analysis
   • Economic Impact
5. Recombinant Erythropoietin Market , By Drug Type, 2018-2030, (US$ billion)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019–2030
     • Segment Trends
   • Epoetin-alfa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ billion)
   • Epoetin-beta
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ billion)
   • Darbepoetin-alfa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ billion)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ billion)
6. Recombinant Erythropoietin Market, By Application, 2018-2030, (US$ billion)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019–2030
     • Segment Trends
   • Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ billion)
   • Hematology
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ billion)
   • Renal diseases
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ billion)
   • Neurology
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ billion)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ billion)
7. Recombinant Erythropoietin Market , By Distribution Channel, 2018-2030, (US$ billion)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019–2030
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ billion)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ billion)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ billion)
8. Recombinant Erythropoietin Market , By Region, 2018-2030, (US$ billion)
   • Introduction
     • Market Share Analysis, By Country, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, For Country 2019–2030
     • Country Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018-2030,(US$ billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ billion)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 - 2030, (US$ Bn)
       • U.S.
       • Canada
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018-2030,(US$ billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ billion)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 - 2030, (US$ Bn)
       • U.K.
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018-2030,(US$ billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ billion)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 - 2030, (US$ Bn)
       • China
       • India
       • Japan
       • ASEAN
       • Australia
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018-2030,(US$ billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ billion)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 - 2030, (US$ Bn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018-2030,(US$ billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ billion)
     • 2018 - 2030, (US$ Bn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018-2030,(US$ billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ billion)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region,  2018 - 2030, (US$ Bn)
       • North Africa
       • Central Africa
       • South Africa
9. Competitive Landscape
   • • Amgen Inc.
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Johnson & Johnson (Janssen Pharmaceuticals)
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Pfizer Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • F. Hoffmann-La Roche AG
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Novartis AG
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Biocon Limited
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • LG Chem Ltd.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Intas Pharmaceuticals Ltd.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Dr. Reddy's Laboratories Ltd.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Celltrion Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • 3SBio Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • BioSidus SA
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Astellas Pharma Inc
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
     • Lotus Pharmaceutical Co., Ltd
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
   • Analyst Views
10. Section
    • Research Methodology
    • About us

*Browse 35 market data tables and 34 figures on "Global Recombinant Erythropoietin Market” - Global forecast to 2030